DiCE Molecules attracts $60m
DiCE Molecules, a biopharmaceutical company, has raised $60 million in Series C-1 financing.
DiCE Molecules, a biopharmaceutical company, has raised $60 million in Series C-1 financing.
Copyright PEI Media
Not for publication, email or dissemination